Episode Details
Back to EpisodesNew Data on Risk Factors and Treatment Regimens for Patients With Neovascular AMD and DME
Episode 616
Published 7 months, 1 week ago
Description
Drs. Vakharia and Danzig highlight new AAO 2025 data on high-dose aflibercept, sleep apnea as a potential AMD risk factor, and an AI-guided anti-VEGF regimen that cuts injections while maintaining vision. Together, these advances point toward more personalized, efficient care for patients with neovascular AMD and DME.